Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue

被引:29
作者
Barcelo-Batllori, Silvia [1 ]
Kalko, Susana G. [2 ]
Esteban, Yaiza [1 ]
Moreno, Slivia [1 ]
Carmona, Maria C. [1 ]
Gomis, Ramon [1 ]
机构
[1] Hosp Clin Barcelona, Endocrinol & Diabet Unit, Lab Expt Diabet & Obes, IDIBAPS, E-08036 Barcelona, Spain
[2] Hosp Clin Barcelona, Bioinformat Unit, IDIBAPS, E-08036 Barcelona, Spain
关键词
HEAT-SHOCK PROTEINS; BODY-WEIGHT GAIN; OXIDATIVE STRESS; SODIUM TUNGSTATE; PHARMACOKINETIC PARAMETERS; INSULIN-RESISTANCE; PROTEOMIC ANALYSIS; DECREASES WEIGHT; GENE-EXPRESSION; OBESITY;
D O I
10.1074/mcp.M700198-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Our previous results demonstrated that tungstate decreased weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation, suggesting that brown adipose tissue was one of the targets of its antiobesity effect. To identify potential targets of tungstate, we used DIGE to compare brown adipose tissue protein extracts from the following experimental groups: untreated lean, tungstate-treated lean, untreated obese, and tungstate-treated obese rats. To distinguish direct targets of tungstate action from those that are secondary to body weight loss, we also included in the analysis an additional group consisting of obese rats that lose weight by caloric restriction. Hierarchical clustering of analysis of variance and t test contrasts clearly separated the different experimental groups. DIGE analysis identified 20 proteins as tungstate obesity direct targets involved in Krebs cycle, glycolysis, lipolysis and fatty acid oxidation, electron transport, and redox. Protein oxidation was decreased by tungstate treatment, confirming a role in redox processes; however, palmitate oxidation, as a measure of fatty acid beta-oxidation, was not altered by tungstate, thus questioning its putative function in fatty acid oxidation. Protein network analyses using Ingenuity Pathways Analysis highlighted peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) as a potential target. We confirmed by real time PCR that indeed tungstate up-regulates PGC-1 alpha, and its major target, uncoupling protein 1, was also increased as shown by Western blot. These results illustrate the utility of proteomics and bioinformatics approaches to identify targets of obesity therapies and suggest that in brown adipose tissue tungstate modulates redox processes and increases energy dissipation through uncoupling and PGC-1 alpha up-regulation, thus contributing to its overall antiobesity effect.
引用
收藏
页码:378 / 393
页数:16
相关论文
共 59 条
[1]   In-depth analysis of the adipocyte proteome by mass spectrometry and bioinformatics [J].
Adachi, Jun ;
Kumar, Chanchal ;
Zhang, Yanling ;
Mann, Matthias .
MOLECULAR & CELLULAR PROTEOMICS, 2007, 6 (07) :1257-1273
[2]  
Anderson RA, 2000, DIABETES METAB, V26, P22
[3]   A proteomic screen identified stress-induced chaperone proteins as targets of Akt phosphorylation in mesangial cells [J].
Barati, Michelle T. ;
Rane, Madhavi J. ;
Klein, Jon B. ;
McLeish, Kenneth R. .
JOURNAL OF PROTEOME RESEARCH, 2006, 5 (07) :1636-1646
[4]  
BARBERA A, 1994, J BIOL CHEM, V269, P20047
[5]   Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats [J].
Barceló-Batllori, S ;
Corominola, H ;
Claret, M ;
Canals, I ;
Guinovart, J ;
Gomis, R .
PROTEOMICS, 2005, 5 (18) :4927-4935
[6]  
Barceló-Batllori S, 2002, PROTEOMICS, V2, P551, DOI 10.1002/1615-9861(200205)2:5<551::AID-PROT551>3.0.CO
[7]  
2-O
[8]   Current and investigational antiobesity agents and obesity therapeutic treatment targets [J].
Bays, HE .
OBESITY RESEARCH, 2004, 12 (08) :1197-1211
[9]   Role of insulin action and cell size on protein expression patterns in adipocytes [J].
Blüher, M ;
Wilson-Fritch, L ;
Leszyk, J ;
Laustsen, PG ;
Corvera, S ;
Kahn, CR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (30) :31902-31909
[10]  
Bonnefont Jean-Paul, 2004, Molecular Aspects of Medicine, V25, P495, DOI 10.1016/j.mam.2004.06.004